Structure Therapeutics develops oral small molecule drugs that target G protein coupled receptors to treat chronic diseases, mainly obesity. It last closed at $16.13 on Nov 20, down 5.78% on the day. The next earnings report for GPCR is expected around Thu, Feb 25, 2027, after the close. For the quarter ended Sep 2026, GPCR reported EPS of -$0.66. Over its last 8 reports the stock moved an average of 2.1% the session after earnings.
AI Auto Pilots
Is GPCR in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold GPCR.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on GPCRStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
GPCR · as of the Nov 20 close · updated each morning
Downtrend, oversold
The stock is 24% below its 20 day and 58% below its 50 day average. It is 173% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 22), oversold. The nearest support is the 52 week low at $16.06, and the nearest resistance the Pivot at $16.42.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 8.8%/day
Key levels
$94.9052 week high+488.3%
$43.96200 day average+172.5%
$37.62100 day average+133.2%
$25.4950 day average+58.0%
$22.36Swing high (Oct 30)+38.6%
$19.9920 day average+23.9%
$16.79Pivot R1+4.1%
$16.42Pivot+1.8%
$16.13Last close
$16.0652 week low−0.4%
$15.77Pivot S1−2.2%
Indicators
RSI (14)
22.38
Oversold below 30
Oversold
MACD
-2.34
Above its signal line
Bullish
Stochastic
1.8
Near the bottom of its range
Oversold
ADX (14)
53.7
Strong downtrend
Williams %R
-99.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-191.7
Oversold below −100, overbought above 100
Oversold
Rate of change
−20.7%
Change over 10 sessions
Bearish
ATR (14)
$1.41
Typical daily range, 8.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Falling, oversold
Short trendBearish
Long trendNot enough history
MomentumWeak
StretchOversold
VolatilityNormal, 31.9%/day
Key levels
$94.9052 week high+488.3%
$43.96200 day average+172.5%
$37.62100 day average+133.2%
$25.4950 day average+58.0%
$22.36Swing high (Oct 30)+38.6%
$19.9920 day average+23.9%
$16.79Pivot R1+4.1%
$16.42Pivot+1.8%
$16.13Last close
$16.0652 week low−0.4%
$15.77Pivot S1−2.2%
Indicators
RSI (14)
24.48
Oversold below 30
Oversold
MACD
-8.03
Below its signal line
Bearish
Stochastic
2.7
Near the bottom of its range
Oversold
ADX (14)
29.1
Trending down
Williams %R
-99.8
Oversold below −80, overbought above −20
Oversold
CCI (20)
-110.5
Oversold below −100, overbought above 100
Oversold
Rate of change
−58.3%
Change over 10 sessions
Bearish
ATR (14)
$5.14
Typical daily range, 31.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200–
What happened before, for GPCR
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how GPCR did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow GPCR usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for GPCRHow many large options trades hit GPCR, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in GPCR in the last 90 days.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether GPCR is in one of them and how their past GPCR trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About Structure Therapeutics
Structure Therapeutics is a biopharmaceutical company based in South San Francisco, California. It is developing oral small molecule drugs that act on G protein coupled receptors, a family of receptors that control many body processes. Its most advanced candidate is aimed at obesity, and its pipeline includes other candidates for metabolic and related conditions. The company is still in clinical development, and its medicines are intended for patients with chronic diseases.